Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chesnara ( (GB:CSN) ) has shared an update.
Chesnara plc has issued and admitted to trading additional ordinary shares on the London Stock Exchange in connection with its 2023 short‑term and long‑term incentive schemes and its 2022 savings-related share option plan. The new allotments, totalling 165,834 fully fungible ordinary shares, increase the company’s issued share capital to 230,960,110 shares, modestly diluting existing holders while facilitating employee and management participation in the group’s equity.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £360.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Spark’s Take on CSN Stock
According to Spark, TipRanks’ AI Analyst, CSN is a Neutral.
The score is held back primarily by inconsistent profitability and especially unstable cash flow, despite a currently strong balance sheet. Technically, the stock shows a weak trend (below key moving averages and negative MACD), while valuation is supported by a very high dividend yield but tempered by negative earnings (negative P/E).
To see Spark’s full report on CSN stock, click here.
More about Chesnara
Chesnara plc is a FTSE 250 European life, pensions and investment group with specialist expertise in insurance consolidation. It administers around 1.4 million policies through business units in the UK, the Netherlands and Sweden, focusing on efficient policy administration, selective new business and value-adding acquisitions, and has increased its dividend for 21 consecutive years.
Average Trading Volume: 691,485
Technical Sentiment Signal: Buy
Current Market Cap: £709M
For an in-depth examination of CSN stock, go to TipRanks’ Overview page.

